Articles from Rowe Plastic Surgery

Mandelbaum Barrett PC healthcare litigation team, led by Mohamed H. Nabulsi and Todd M. Nosher, Esqs., has been retained by Norman M. Rowe, M.D., Norman M. Rowe, M.D. PLLC, M. Rowe MD of New Jersey LLC, Rowe Plastic Surgery of New Jersey LLC and East Coast Plastic Surgery PLLC PA (collectively, the “Clients”) in connection with a federal civil action recently filed by EmblemHealth Inc. (“Emblem”). Emblem is seeking to unwind over 20 final arbitration awards against it arising from independent dispute resolution (“IDR”) proceedings held pursuant to and in strict accordance with statutory law under the federal No Surprises Act (“NSA”). The awards, dating back as far as 2024, were issued by qualified, neutral arbiters (Certified Independent Dispute Resolution Entities (“IDREs”), who carefully considered the parties’ positions and made their decisions based on specific factors mandated by law. Emblem—who fully participated in each disputed arbitration—never challenged the final awards before this Action.